{"id":"https://openalex.org/W2120084347","doi":"https://doi.org/10.1158/1535-7163.mct-08-1004","title":"Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice","display_name":"Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice","publication_year":2009,"publication_date":"2009-06-01","ids":{"openalex":"https://openalex.org/W2120084347","doi":"https://doi.org/10.1158/1535-7163.mct-08-1004","mag":"2120084347","pmid":"https://pubmed.ncbi.nlm.nih.gov/19509267"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-08-1004","doi":"https://doi.org/10.1158/1535-7163.mct-08-1004","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-08-1004","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000344564","display_name":"Sharmila Shankar","orcid":"https://orcid.org/0000-0002-2854-3678","observed_orcids":["https://orcid.org/0000-0002-2854-3678"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I165139151","display_name":"University of North Texas Health Science Center","ror":"https://ror.org/05msxaq47","country_code":"US","type":"education","lineage":["https://openalex.org/I165139151"]},{"id":"https://openalex.org/I90436673","display_name":"The University of Texas Health Science Center at Tyler","ror":"https://ror.org/01sps7q28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I90436673"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharmila Shankar","raw_affiliation_strings":["1Department of Biochemistry, Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, Texas; 2Department of Biostatistics, University of North Texas Health Science Center at Fort Worth, Fort Worth, Texas; 3Department of Investigational Cancer Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; and 4Baltimore VA Medical Center, University of Maryland School of Medicine, Greenebaum Cancer Center, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Biochemistry, Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, Texas; 2Department of Biostatistics, University of North Texas Health Science Center at Fort Worth, Fort Worth, Texas; 3Department of Investigational Cancer Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; and 4Baltimore VA Medical Center, University of Maryland School of Medicine, Greenebaum Cancer Center, Baltimore, Maryland","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I165139151","https://openalex.org/I90436673"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065319652","display_name":"Rachel B. Davis","orcid":"https://orcid.org/0000-0003-4805-1504","observed_orcids":["https://orcid.org/0000-0003-4805-1504"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I165139151","display_name":"University of North Texas Health Science Center","ror":"https://ror.org/05msxaq47","country_code":"US","type":"education","lineage":["https://openalex.org/I165139151"]},{"id":"https://openalex.org/I90436673","display_name":"The University of Texas Health Science Center at Tyler","ror":"https://ror.org/01sps7q28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I90436673"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachel Davis","raw_affiliation_strings":["1Department of Biochemistry, Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, Texas; 2Department of Biostatistics, University of North Texas Health Science Center at Fort Worth, Fort Worth, Texas; 3Department of Investigational Cancer Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; and 4Baltimore VA Medical Center, University of Maryland School of Medicine, Greenebaum Cancer Center, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Biochemistry, Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, Texas; 2Department of Biostatistics, University of North Texas Health Science Center at Fort Worth, Fort Worth, Texas; 3Department of Investigational Cancer Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; and 4Baltimore VA Medical Center, University of Maryland School of Medicine, Greenebaum Cancer Center, Baltimore, Maryland","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I165139151","https://openalex.org/I90436673"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043999741","display_name":"Karan P. Singh","orcid":"https://orcid.org/0000-0002-1841-846X","observed_orcids":["https://orcid.org/0000-0002-1841-846X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I165139151","display_name":"University of North Texas Health Science Center","ror":"https://ror.org/05msxaq47","country_code":"US","type":"education","lineage":["https://openalex.org/I165139151"]},{"id":"https://openalex.org/I90436673","display_name":"The University of Texas Health Science Center at Tyler","ror":"https://ror.org/01sps7q28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I90436673"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karan P. Singh","raw_affiliation_strings":["1Department of Biochemistry, Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, Texas; 2Department of Biostatistics, University of North Texas Health Science Center at Fort Worth, Fort Worth, Texas; 3Department of Investigational Cancer Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; and 4Baltimore VA Medical Center, University of Maryland School of Medicine, Greenebaum Cancer Center, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Biochemistry, Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, Texas; 2Department of Biostatistics, University of North Texas Health Science Center at Fort Worth, Fort Worth, Texas; 3Department of Investigational Cancer Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; and 4Baltimore VA Medical Center, University of Maryland School of Medicine, Greenebaum Cancer Center, Baltimore, Maryland","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I165139151","https://openalex.org/I90436673"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I165139151","display_name":"University of North Texas Health Science Center","ror":"https://ror.org/05msxaq47","country_code":"US","type":"education","lineage":["https://openalex.org/I165139151"]},{"id":"https://openalex.org/I90436673","display_name":"The University of Texas Health Science Center at Tyler","ror":"https://ror.org/01sps7q28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I90436673"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Razelle Kurzrock","raw_affiliation_strings":["1Department of Biochemistry, Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, Texas; 2Department of Biostatistics, University of North Texas Health Science Center at Fort Worth, Fort Worth, Texas; 3Department of Investigational Cancer Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; and 4Baltimore VA Medical Center, University of Maryland School of Medicine, Greenebaum Cancer Center, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Biochemistry, Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, Texas; 2Department of Biostatistics, University of North Texas Health Science Center at Fort Worth, Fort Worth, Texas; 3Department of Investigational Cancer Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; and 4Baltimore VA Medical Center, University of Maryland School of Medicine, Greenebaum Cancer Center, Baltimore, Maryland","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I165139151","https://openalex.org/I90436673"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103376886","display_name":"Douglas D. Ross","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I165139151","display_name":"University of North Texas Health Science Center","ror":"https://ror.org/05msxaq47","country_code":"US","type":"education","lineage":["https://openalex.org/I165139151"]},{"id":"https://openalex.org/I90436673","display_name":"The University of Texas Health Science Center at Tyler","ror":"https://ror.org/01sps7q28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I90436673"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas D. Ross","raw_affiliation_strings":["1Department of Biochemistry, Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, Texas; 2Department of Biostatistics, University of North Texas Health Science Center at Fort Worth, Fort Worth, Texas; 3Department of Investigational Cancer Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; and 4Baltimore VA Medical Center, University of Maryland School of Medicine, Greenebaum Cancer Center, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Biochemistry, Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, Texas; 2Department of Biostatistics, University of North Texas Health Science Center at Fort Worth, Fort Worth, Texas; 3Department of Investigational Cancer Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; and 4Baltimore VA Medical Center, University of Maryland School of Medicine, Greenebaum Cancer Center, Baltimore, Maryland","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I165139151","https://openalex.org/I90436673"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038606074","display_name":"Rakesh K. Srivastava","orcid":"https://orcid.org/0000-0003-3112-4252","observed_orcids":["https://orcid.org/0000-0003-3112-4252"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I165139151","display_name":"University of North Texas Health Science Center","ror":"https://ror.org/05msxaq47","country_code":"US","type":"education","lineage":["https://openalex.org/I165139151"]},{"id":"https://openalex.org/I90436673","display_name":"The University of Texas Health Science Center at Tyler","ror":"https://ror.org/01sps7q28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I90436673"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rakesh K. Srivastava","raw_affiliation_strings":["1Department of Biochemistry, Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, Texas; 2Department of Biostatistics, University of North Texas Health Science Center at Fort Worth, Fort Worth, Texas; 3Department of Investigational Cancer Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; and 4Baltimore VA Medical Center, University of Maryland School of Medicine, Greenebaum Cancer Center, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Biochemistry, Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, Texas; 2Department of Biostatistics, University of North Texas Health Science Center at Fort Worth, Fort Worth, Texas; 3Department of Investigational Cancer Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; and 4Baltimore VA Medical Center, University of Maryland School of Medicine, Greenebaum Cancer Center, Baltimore, Maryland","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I165139151","https://openalex.org/I90436673"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.0834,"has_fulltext":false,"cited_by_count":59,"citation_normalized_percentile":{"value":0.92182719,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"8","issue":"6","first_page":"1596","last_page":"1605"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vorinostat","display_name":"vorinostat","score":0.9980000257492065},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.9150000214576721},{"id":"https://openalex.org/keywords/trail-resistance","display_name":"TRAIL resistance","score":0.996999979019165},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8870000243186951},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6100000143051147},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8199999928474426},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.9120000004768372},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.9810000061988831},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.8429999947547913},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.6899999976158142},{"id":"https://openalex.org/keywords/tumor-necrosis-factor-related-apoptosis-inducing-ligand","display_name":"tumor necrosis factor-related apoptosis-inducing ligand","score":0.8140000104904175},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor-receptor-2","display_name":"vascular endothelial growth factor receptor 2","score":0.7310000061988831},{"id":"https://openalex.org/keywords/tumor-suppressor-proteins","display_name":"tumor suppressor proteins","score":0.32899999618530273}],"concepts":[{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.6856781840324402},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6653782725334167},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.6340048313140869},{"id":"https://openalex.org/C2776262904","wikidata":"https://www.wikidata.org/wiki/Q905901","display_name":"Vorinostat","level":5,"score":0.6218060255050659},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4483656585216522},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.42302781343460083},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3403511345386505},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3380337953567505},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.30664709210395813},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.286220908164978},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20870652794837952},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.0},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077337","descriptor_name":"Vorinostat","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006655","descriptor_name":"Histone Deacetylases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006877","descriptor_name":"Hydroxamic Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008325","descriptor_name":"Mammary Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008325","descriptor_name":"Mammary Neoplasms, Experimental","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008325","descriptor_name":"Mammary Neoplasms, Experimental","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D015850","descriptor_name":"Interleukin-6","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015850","descriptor_name":"Interleukin-6","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020133","descriptor_name":"Reverse Transcriptase Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020782","descriptor_name":"Matrix Metalloproteinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020782","descriptor_name":"Matrix Metalloproteinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D047368","descriptor_name":"Tumor Burden","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053221","descriptor_name":"TNF-Related Apoptosis-Inducing Ligand","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.mct-08-1004","doi":"https://doi.org/10.1158/1535-7163.mct-08-1004","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-08-1004","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:19509267","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19509267","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":59,"referenced_works":["https://openalex.org/W186651553","https://openalex.org/W1486948598","https://openalex.org/W1511815964","https://openalex.org/W1603098046","https://openalex.org/W1963546142","https://openalex.org/W1963549994","https://openalex.org/W1964843472","https://openalex.org/W1968527707","https://openalex.org/W1971284862","https://openalex.org/W1975937960","https://openalex.org/W1976298557","https://openalex.org/W1978480779","https://openalex.org/W1978691010","https://openalex.org/W1981591956","https://openalex.org/W1985826761","https://openalex.org/W1987443571","https://openalex.org/W2016770760","https://openalex.org/W2016823780","https://openalex.org/W2024202249","https://openalex.org/W2030068760","https://openalex.org/W2032077813","https://openalex.org/W2033341544","https://openalex.org/W2035552458","https://openalex.org/W2037920224","https://openalex.org/W2052779043","https://openalex.org/W2053058618","https://openalex.org/W2055031207","https://openalex.org/W2062036842","https://openalex.org/W2066264051","https://openalex.org/W2070433411","https://openalex.org/W2071295595","https://openalex.org/W2072292536","https://openalex.org/W2086619383","https://openalex.org/W2087334011","https://openalex.org/W2090465622","https://openalex.org/W2091028211","https://openalex.org/W2092670120","https://openalex.org/W2095228162","https://openalex.org/W2095279010","https://openalex.org/W2098280101","https://openalex.org/W2100918430","https://openalex.org/W2114468318","https://openalex.org/W2124231612","https://openalex.org/W2130503287","https://openalex.org/W2132358441","https://openalex.org/W2133395596","https://openalex.org/W2138306378","https://openalex.org/W2141584283","https://openalex.org/W2150491978","https://openalex.org/W2152888668","https://openalex.org/W2156575042","https://openalex.org/W2330709458","https://openalex.org/W3167169307","https://openalex.org/W4250428608","https://openalex.org/W4252785935","https://openalex.org/W6642789923","https://openalex.org/W6668431280","https://openalex.org/W6680536075","https://openalex.org/W6681006751"],"related_works":["https://openalex.org/W2037975991","https://openalex.org/W2058225015","https://openalex.org/W2426034980","https://openalex.org/W2067419747","https://openalex.org/W2091309325","https://openalex.org/W2020047873","https://openalex.org/W1995443667","https://openalex.org/W2024202249","https://openalex.org/W2245743546","https://openalex.org/W4309157552"],"abstract_inverted_index":{"The":[0,57,114],"purpose":[1],"of":[2,59,66,91,100,117,145,153,179,190,195,206,212],"this":[3],"study":[4],"was":[5,86,125],"to":[6,77,264],"examine":[7],"whether":[8],"histone":[9],"deacetylase":[10],"inhibitor":[11,189,194],"suberoylanilide":[12],"hydroxamic":[13],"acid":[14],"(SAHA;":[15],"Zolinza/vorinostat)":[16],"could":[17],"sensitize":[18],"tumor":[19,62,101,130,198,207,253],"necrosis":[20],"factor-related":[21],"apoptosis-inducing":[22],"ligand":[23],"(TRAIL)-resistant":[24],"breast":[25,266],"carcinoma":[26],"in":[27,94,128,151,197,252],"vivo.":[28],"BALB/c":[29],"nude":[30,95,118,146],"mice":[31,96,119,147,202],"were":[32,71],"orthotopically":[33],"implanted":[34],"with":[35,42,120,148,232,243],"TRAIL-resistant":[36,75],"MDA-MB-468":[37,92],"cells":[38,230],"and":[39,64,69,105,107,112,133,135,156,174,177,192,220,256,258],"treated":[40],"i.v.":[41],"SAHA,":[43],"TRAIL,":[44],"or":[45,214,234],"SAHA":[46,73,88,121,139,149,235,244],"followed":[47,122,245],"by":[48,97,123,246],"TRAIL":[49,84,124,247],"for":[50],"four":[51],"times":[52],"during":[53],"first":[54],"3":[55],"weeks.":[56],"effects":[58],"drugs":[60],"on":[61],"growth":[63,90,166,208,225],"markers":[65,99],"apoptosis,":[67],"metastasis,":[68],"angiogenesis":[70],"examined.":[72],"sensitized":[74],"xenografts":[76,93],"undergo":[78],"apoptosis":[79,137],"through":[80],"multiple":[81,250],"mechanisms.":[82],"Whereas":[83],"alone":[85],"ineffective,":[87],"inhibited":[89],"inhibiting":[98,129],"cell":[102,109],"proliferation,":[103],"angiogenesis,":[104,132,255],"metastasis":[106,134,257],"inducing":[108,136],"cycle":[110],"arrest":[111],"apoptosis.":[113],"sequential":[115,241],"treatment":[116,242],"more":[126],"effective":[127],"growth,":[131],"than":[138],"alone,":[140],"without":[141],"overt":[142],"toxicity.":[143],"Treatment":[144],"resulted":[150],"down-regulation":[152],"nuclear":[154],"factor-kappaB":[155],"its":[157],"gene":[158],"products":[159],"(cyclin":[160],"D1,":[161],"Bcl-2,":[162],"Bcl-X(L),":[163],"vascular":[164,223],"endothelial":[165,224,229],"factor,":[167],"hypoxia-inducible":[168],"factor-1alpha,":[169],"interleukin-6,":[170],"interleukin-8,":[171],"matrix":[172,175],"metalloproteinase-2,":[173],"metalloproteinase-9)":[176],"up-regulation":[178],"DR4,":[180],"DR5,":[181],"Bak,":[182],"Bax,":[183],"Bim,":[184],"Noxa,":[185],"PUMA,":[186],"p21(CIP1),":[187],"tissue":[188,193],"metalloproteinase-1,":[191],"metalloproteinase-2":[196],"cells.":[199],"Furthermore,":[200],"control":[201],"showing":[203],"increased":[204,210,221],"rate":[205],"had":[209],"numbers":[211],"CD31(+)":[213],"von":[215],"Willebrand":[216],"factor-positive":[217],"blood":[218],"vessels":[219],"circulating":[222],"factor":[226],"receptor":[227],"2-positive":[228],"compared":[231],"SAHA-treated":[233],"plus":[236],"TRAIL-treated":[237],"mice.":[238],"In":[239],"conclusion,":[240],"may":[248],"target":[249],"pathways":[251],"progression,":[254],"represents":[259],"a":[260],"novel":[261],"therapeutic":[262],"approach":[263],"treat":[265],"cancer.":[267]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":10}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}